AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)
CUSIP: 00901B105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 67,129,058
- Total 13F shares
- 4,487,861
- Share change
- -276,296
- Total reported value
- $3,007,274
- Price per share
- $0.67
- Number of holders
- 30
- Value change
- -$158,270
- Number of buys
- 8
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00901B105:
Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,988,704
|
$855,142 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
817,127
|
$351,365 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.91%
|
610,577
|
$262,548 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
380,905
|
$163,789 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
173,103
|
$74,434 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
168,708
|
$73,000 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.21%
|
144,000
|
$61,920 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
108,900
|
$46,827 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
86,517
|
$37,202 | — | 31 Mar 2023 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.06%
|
40,000
|
$17,000 | — | 31 Mar 2023 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.06%
|
37,063
|
$15,937 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
29,924
|
$12,867 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
25,268
|
$10,865 | — | 31 Mar 2023 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
20,340
|
$9,000 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
20,300
|
$9,000 | — | 31 Mar 2023 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.03%
|
20,000
|
$8,600 | — | 31 Mar 2023 | |
| ForthRight Wealth Management, LLC |
13F
|
Company |
0.03%
|
20,000
|
$8,600 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
16,610
|
$7,142 | — | 31 Mar 2023 | |
| Community Bank, N.A. |
13F
|
Company |
0.02%
|
13,226
|
$5,687 | — | 31 Mar 2023 | |
| Traynor Capital Management, Inc. |
13F
|
Company |
0.02%
|
11,777
|
$5,064 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,012
|
$4,305 | — | 31 Mar 2023 | |
| SNS Financial Group, LLC |
13F
|
Company |
0.01%
|
10,000
|
$4,300 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,658
|
$1,000 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,276
|
$979 | — | 31 Mar 2023 | |
| Stephens Consulting, LLC |
13F
|
Company |
0%
|
1,500
|
$645 | — | 31 Mar 2023 | |
| HOEY INVESTMENTS, INC |
13F
|
Company |
0%
|
1,000
|
$430 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
732
|
$315 | — | 31 Mar 2023 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
500
|
$215 | — | 31 Mar 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
170
|
$96 | — | 31 Mar 2023 | |
| Creative Capital Management Investments LLC |
13F
|
Company |
0%
|
200
|
$86 | — | 31 Mar 2023 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
57
|
$25 | — | 31 Mar 2023 | |
| New Millennium Group LLC |
13F
|
Company |
0%
|
33
|
$14 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
13
|
$6 | — | 31 Mar 2023 | |
| Ellen M. Lintal |
3/4/5
|
Former Chief Financial Officer |
—
class O/S missing
|
50,000
|
— | — | 04 Apr 2022 |
Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q2 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.